Patients with chronic obstructive pulmonary disease with acute exacerbation and stable levels of IL-6 Detection and Analysis of Clinical.docVIP

 PAGE \* MERGEFORMAT 10 Patients with chronic obstructive pulmonary disease with acute exacerbation and stable levels of IL-6 Detection and Analysis of Clinical [Abstract] Objective To determine the chronic obstructive pulmonary disease (COPD) patients with acute exacerbation of serum IL 6 levels were observed. Methods double antibody sandwich ELISA method in patients with COPD before and after treatment levels of serum IL 6. Results COPD patients before IL 6 levels compared with control group difference was significant (P lt;0.01), after treatment the level before the difference is also very significant (P lt;0.01). Conclusion COPD serum IL 6 levels and disease development and prognosis . [Keywords:] pulmonary disease, chronic obstructive; interleukin-6; acute attack As society develops, people’s living standard continues to improve, the elderly population continues to increase. China has entered the aging society in advance, and many age-related diseases, people are gradually expanding the age range is also ahead of the trend. Chronic obstructive pulmonary disease (chronic obstructive pulmonary disease, COPD) is a middle-aged clinical common disease, has become the world’s fourth leading cause of death worldwide, serious harm to human health. According to reports, annual deaths due to chronic obstructive pulmonary disease number of 100 million, 500 million people in 1000 due to chronic obstructive pulmonary disease and disability; WHO estimated that by 2020 COPD will become the world’s fifth economic burden of disease [1]. This is not only to patients and families with to harm, but also to society as a whole was a tremendous financial burden. COPD patients of the current biological, biochemical and energy metabolism such as cytokines, hormones, receptors and other changes, has been in the medical and research institutions at all levels generally carried out , and gradually become a research hotspot. This article discusses acute exacerbation of COPD p